SEC Form 4 · accession 0001104659-18-021354
Avalo Therapeutics, Inc. · AVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Greenleaf
Officer — Chief Executive Officer · Director
Period of report
Mar 27, 2018
Accepted (ET)
Mar 29, 2018 · 6:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534120
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 27, 2018 | A | 400,000 | $0.00 | A | 400,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $4.24 | Mar 27, 2018 | A | 500,000 | A | — | Mar 27, 2028 | Common Stock | 500,000 | 500,000 | D |
| Employee Stock Option (Right to Buy)F3 | $4.24 | Mar 27, 2018 | A | 500,000 | A | — | Mar 27, 2028 | Common Stock | 500,000 | 500,000 | D |
| Stock Option (Right to Buy)F4 | $0.80 | holding | — | — | — | — | May 11, 2027 | Common Stock | 16,714 | 16,714 | D |
| Employee Stock Option (Right to Buy)F5 | $0.57 | holding | — | — | — | Jun 30, 2018 | Jun 29, 2027 | Common Stock | 8,357 | 8,357 | D |
Explanation of responses
- F1Represents restricted stock which vests in four equal annual installments beginning on March 27, 2019, provided the Reporting Person is then an officer of the Issuer on each such vesting date. The tax liability upon the vesting of the first annual installment shall be covered by the Issuer and the remaining tax liabilities upon the vesting of the second, third and fourth annual installments shall be covered by the Reporting Person.
- F2The stock option will vest 25% on the first anniversary of the date of grant and the remaining 75% of the shares subject to the stock option shall vest in equal monthly installments on each monthly anniversary date of the first vesting date over the following 48 months beginning on April 27, 2019, provided the Reporting Person is then an officer of the Issuer on each such vesting date.
- F3The stock option will vest in full upon the Issuer's common stock closing at or above $12.50 per share for three consecutive trading days, provided the Reporting Person is then an officer of the Issuer on each such vesting date.
- F4The stock option will vest in three substantially equal annual installments on May 11, 2018, 2019 and 2020, subject to the Reporting Person's continued service on each such vesting date.
- F5The stock options will vest in full on June 30, 2018, subject to the Reporting Person's continued service on such vesting date.